Warfarin and vitamin K intake in the era of pharmacogenetics.
about
A Possible Effect of Concentrated Oolong Tea Causing Transient Ischemic Attack-Like SymptomsSwitching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy.Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement.Vitamin C deficiency in an anticoagulated patient.Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisTreatment of warfarin-associated coagulopathy with vitamin K.Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project.New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism.Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.Dosage individualization of warfarin using artificial neural networks.Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.Metabolic engineering of menaquinone-8 pathway of Escherichia coli as a microbial platform for vitamin K production.The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.Pharmacogenomics Aspect of Warfarin Therapy
P2860
Q30829182-F86C3B35-6717-4E00-B506-C326A104AB8BQ35684803-3B5B188A-B76D-431F-A45E-3893AE9291EBQ36272032-B866306E-7597-44D6-BECE-5CFBF5848B20Q36855608-A3E359E2-0A69-4248-B40E-8BB332A940E8Q36874914-ED451C26-14C0-464D-BFA3-AB292F0A542EQ37065161-D2A60D1D-313F-40E8-A54B-7C07674BC411Q37955232-41F7C748-43B9-4B95-9D7E-4C6A12664EDFQ38024092-177A0801-9F18-41A6-8D19-4BF24632DF3EQ38162813-C60560AE-B50C-457C-BF7A-D301DB2263A3Q39213540-6D395A9C-F944-4876-86AE-76ED3A06709FQ39537454-2539044B-1EB9-4D02-83BB-C3C8F3D579F5Q47371128-0027038B-F5C5-414B-927C-36C7FF3EF3C9Q47823825-C26ABFD0-CC1A-4C56-A8AE-C93FD5D3EE0DQ51107902-AB75A5DE-1E0E-4F44-B745-D1F710840AF4Q51335958-B92C0947-15F2-48AE-B3CD-A436AF1D0EABQ54364476-4BCD1A93-6EBE-4B64-B554-34442E8B883EQ54961174-CEEC5F8E-AFD1-4AB7-BF70-2682FB8E27EEQ57179825-8E827B36-8A82-4F41-934F-7B264E71632E
P2860
Warfarin and vitamin K intake in the era of pharmacogenetics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Warfarin and vitamin K intake in the era of pharmacogenetics.
@ast
Warfarin and vitamin K intake in the era of pharmacogenetics.
@en
Warfarin and vitamin K intake in the era of pharmacogenetics.
@nl
type
label
Warfarin and vitamin K intake in the era of pharmacogenetics.
@ast
Warfarin and vitamin K intake in the era of pharmacogenetics.
@en
Warfarin and vitamin K intake in the era of pharmacogenetics.
@nl
prefLabel
Warfarin and vitamin K intake in the era of pharmacogenetics.
@ast
Warfarin and vitamin K intake in the era of pharmacogenetics.
@en
Warfarin and vitamin K intake in the era of pharmacogenetics.
@nl
P2093
P2860
P1476
Warfarin and vitamin K intake in the era of pharmacogenetics.
@en
P2093
Daniel Kurnik
Hillel Halkin
Ronen Loebstein
Shlomo Almog
Yael Lurie
P2860
P304
P356
10.1111/J.1365-2125.2010.03672.X
P407
P577
2010-08-01T00:00:00Z